Abstract
Purpose: To estimate microscopic tumordose enhancement due to goldnanoparticles during goldnanoparticle‐aidedradiation therapy (GNRT). Method and Materials: GNRT is an emerging treatment modality currently under development, based on the following observations: a) high tumor specificity of goldnanoparticles due to passive extravasation; b) significant tumordose enhancement during x‐ray irradiation as a result of increased photoelectric absorption due to high atomic number (Z) of gold. A previous Monte Carlo study provided some quantitative estimation of macroscopic dose enhancement (i.e., the average dose enhancement over the entire tumor volume) for a number of GNRT scenarios, which is useful to understand potential therapeutic outcome, in terms of a conventional dose response scheme. On the other hand, the magnitude of physical dose enhancement at the cellular level is expected to be drastically different from that averaged over the tumor volume. Therefore, the current study attempted to estimate microscopic tumordose enhancement for a clinically feasible GNRT scenario using diagnostic energy range x‐rays. Specifically, after obtaining secondary electron spectra due to interactions between 140 kV x‐rays and goldnanoparticles, detailed history Monte Carlo calculations were performed at a nanometer scale to estimate the energy deposition by secondary electrons originated from goldnanoparticles.Results: The current results suggest that the microscopic dose enhancement up to a factor of 8 could be possible within 20 microns from a single goldnanoparticle. The results also show that the magnitude of microscopic dose enhancement is a function of the distance from the site of a goldnanoparticle.Conclusion: A drastic tumordose enhancement (i.e., > 100%) at the cellular level could be achievable during GNRT using diagnostic energy range x‐rays. However, an actual radiobiological outcome would depend on a number of factors such as the size, amount, and distribution of goldnanoparticles within the tumor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.